Induction and maintenance of clinical remission by interferon-β in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial-Reference-Cited by-同舟云学术

Induction and maintenance of clinical remission by interferon-β in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial

Published:2002-07 Issue:7 Volume:16 Page:1233-1239
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Musch E.,Andus T.,Malek M.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2002.01264.x/fullpdf

Reference33 articles.

1. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis;Sutherland;Ann Intern Med,1993

2. Metaanalysis of the effectiveness of current drug therapy of ulcerative colitis;Kornbluth;J Clin Gastroenterol,1993

3. Ciclosporin in severe ulcerative colitis refractory to steroid therapy;Lichtiger;N Engl J Med,1994

4. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study;Leijonmarck;Gut,1990

5. Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin;Feshner;Dis Colon Rectum,1995

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical and immunological features of alopecia areata following SARS-CoV-2 infection or COVID-19 vaccines;Expert Opinion on Therapeutic Targets;2024-04-02

2. Commonly prescribed medications associated with alopecia;Journal of the American Academy of Dermatology;2023-06

3. Exposing the Two Contrasting Faces of STAT2 in Inflammation;Journal of Interferon & Cytokine Research;2022-09-01

4. Ulcerative colitis triggered by pegylated interferon alpha-2b in a patient with chronic hepatitis B: A case report and literature review;Liver Research;2021-04

5. Repurposing multiple sclerosis drugs: a review of studies in neurological and psychiatric conditions;Drug Discovery Today;2019-07